缓解动脉样硬化:将疫苗与基因标集成在一起
Alireza Haraj1, Masoomeh Bakhshandeh2, Nafiseh Shokri3
1Student Research Committee, Faculty of Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
American heart journal plus : cardiology research and practice
|August 18, 2025
概括
通过免疫接种向特定抗原显示出减轻动脉样硬化进展的希望. 这种方法旨在降低与这种复杂的心血管疾病相关的高死亡率.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 动脉样硬化斑块的形成涉及细胞功能障碍和血管内的细胞外矩阵重塑.
- 对特定抗原的免疫反应与动脉样硬化的发展和进展有关.
- 像ox-LDL,ApoB-100和interleukins这样的关键抗原在动脉样硬化过程中起着重要的作用.
研究的目的:
- 审查特定基因在触发动脉硬化斑块事件中的作用.
- 提出针对这些基因的免疫策略,以预防动脉样硬化.
- 突出了解免疫-动脉样硬化相互作用对治疗发展的重要性.
主要方法:
- 文献综述专注于动脉样硬化的遗传因素.
- 对免疫系统参与斑块形成的分析.
- 检查各种抗原特异性免疫方法.
主要成果:
- 鉴定了几种促进动脉样硬化斑块发展的基因.
- 针对动脉样硬化相关抗原的向免疫策略的介绍.
- 有证据表明,接种疫苗可以是预防动脉样硬化进展的有效策略.
结论:
- 优化免疫接种需要深入了解免疫系统在动脉样硬化中的作用.
- 通过疫苗接种向特定抗原提供了一个有前途的治疗途径.
- 对动脉样硬化进展的免疫可以显著降低死亡率.
相关概念视频
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Atherosclerosis I: Introduction
77
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
77
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32


